Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy

European Journal of Echocardiography

Volumn 11, Issue 2, 2010, Pages 131-137

  Cabrera Bueno, Fernando ^a   Molina Mora, Maria Jose ^a   Alzueta, Javier ^a   Pena Hernandez, Jose ^a   Jimenez Navarro, Manuel ^a   Fernandez Pastor, Julia ^a   Barrera, Alberto ^a   De Teresa, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Cardiac resynchronization; Mitral regurgitation; Reverse remodelling

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CONFIDENCE INTERVALS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEALTH STATUS INDICATORS; HEART ATRIA; HEART FAILURE; HEART VENTRICLES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949385778     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jep184     Document Type: Article

References (43)

1. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003;91:538-43.
2. Tada H, Tamai J, Takaki H, Ohnishi E, Okano Y, Yoshioka T. Mild mitral regurgitation reduces exercise capacity in patients with idiopathic dilated cardiomyopathy. Int J Cardiol 1997;58:41-5.
3. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke A et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-70.
4. Kanzaki H, Bazaz R, Schwartzman D, Dohi K, Sade LE, Gorcsan J III. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 2004;44:1619-25.
5. Cleland J, Daubert J, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. for the Cardiac Resynchronization-Heart Failure CARE-HF Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
6. Brandt RR, Reiner C, Arnold R, Sperzerl J, Pitschner HF, Hamm CW. Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy. Eur Heart J 2006;27:187-92.
7. Reuter S, Garrigue S, Barold SS, Jais P, Hocini M, Haissaguerre M et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002;89:346-50.
8. Diaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernández-Madrid A et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-40.
9. Cabrera-Bueno F, García-Pinilla JM, Peña-Hernández J, Jiménez-Navarro M, Gómez-Doblas JJ, Barrera-Cordero A et al. Repercussion of functional mitral regurgitation on reverse remodeling in cardiac resynchronization therapy. Europace 2007;9:757-61.
10. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005.: the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-40.
11. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC /AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005;112:1825-52.
12. Enríquez-Sarano M, Basmadjian AJ, Rossi A, Bailey KR, Seward JB, Tajik AJ. Progression of mitral regurgitation: a prospective Doppler echocardiographic study. J Am Coll Cardiol 1999;34:1137-44.
13. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
14. Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 1995;25:703-9.
15. Tischler MD, Niggel J, Borowski DT, LeWinter MM. Relation between left ventricular shape and exercise capacity in patients with left ventricular dysfunction. J Am Coll Cardiol 1993;22:751-7.
16. Lamas GA, Vaughan DE, Parisi EF, Pfeffer MA. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 1989;63:1167-73.
17. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE et al. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-6.
18. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355-9.
19. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction. A quantitative clinical study. Circulation 2000;102:1400-6.
20. Agricola E, Oppizzi M, Galderisi M, Meris A, Pappone C, Margonato A. Role of regional mechanical dyssynchrony as a determinant of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Heart 2006;92:1390-5.
21. Otsuji Y, Handschumacher MD, Liel-Cohen N, Tanabe H, Jiang L, Schwammenthal E et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction:three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001; 37:641-8.
22. Aikawa K, Sheehan FH, Otto CM, Coady K, Bashein G, Bolson EL. The severity of functional mitral regurgitation depends on the shape of the mitral valve apparatus: a three-dimensional echo analysis. J Heart Valve Dis 2002;11:627-36.
23. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Piérard LA et al. Acute effects of initiation and withdrawal of cardiac resyncronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071-7.
24. St John-Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-90.
25. Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008;29:757-65.
26. Abraham WT, Fisher WG, Smith AL, DeLurgio DB, Leon AR, Lon E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
27. Lancellotti P, Mélon P, Sakalihasan N, Waleffe A, Dubois C, Bertholet P et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 2004;94:1462-5.
28. Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation:relationship with left ventricular dyssynchrony, remodeling and cardiopulmonary performance. Eur Heart J 2007;28: 2134-41.
29. Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F et al. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr 2006;7: 31-9.
30. Vinereanu D. Mitral regurgitation and cardiac resynchronization therapy. Echocardiography 2008;25:1155-66.
31. Ypenburg C, van-Bommel RJ, Borleffs JW, Bleeker GB, Boersma E, Schalij MJ et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-90.
32. Carabello BA. Ischemic mitral regurgitation and ventricular remodeling. J Am Coll Cardiol 2004;43:384-5.
33. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. Circulation 2009;119:969-77.
34. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T et al. Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) trial. Circulation 2006;114:2766-72.
35. Cappola TP, Harsch MR, Jessup M, Abraham WT, Young JB, Petersen-Stejskal S et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP and gender. J Card Fail 2006;12:182-8.
36. Richardson M, Freemantle N, Calvert MJ, Cleland JG, Tavazzi L, CARE-HF Study Steering Committee Investigators. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J 2007; 15:1827-34.
37. Cleland JG, Tavazzi L, Daubert JC, Tageldien A, Freemantle N. Cardiac resynchronization therapy. Are modern myths preventing appropriate use? J Am Coll Cardiol 2009;53:608-11.
38. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic signifi-cance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9.
39. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response. A report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol 2008;52: 438-45.
40. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D et al. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail 2008;14:670-5.
41. Carabello BA. The current therapy for mitral regurgitation. J Am Coll Cardiol 2008; 52:319-26.
42. Bolling SF, Smolens IA, Pagani FD. Surgical alternatives for heart failure. J Heart Lung Transplant 2001;20:729-33.
43. Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device European Union study. Circulation 2009;120:326-33.